Harald Hegen

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

Simone Mader, Viktoria Gredler, Kathrin Schanda et al. · Journal of Neuroinflammation · 2011 · 438 citations · Full text

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 290 citations

International multicenter examination of MOG antibody assays

Markus Reindl, Kathrin Schanda, Mark Woodhall et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 262 citations · Full text

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Ester Cantó, Mar Tintoré, Luisa María Villar et al. · Brain · 2015 · 186 citations · Full text

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Charlotte E. Teunissen, Til Menge, Ayşe Altıntaş et al. · Multiple Sclerosis Journal · 2013 · 162 citations

Neuroimaging Biomarkers, Control Groups, Neurological Disorder +15